Paul Bonanos - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Paul Bonanos's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Paul Bonanos
Verified
Biopharma Intelligence, BioCentury
San Francisco
Beats
Outdoor Gear , Trail Running Shoes , Apparel , Consumer Product Reviews , Mobile Tech , Fitness Tech
Technical writing or academic writing.
Content
By Paul Bonanos Verified| BioCentury Verified ARTICLE | DealsUncertainty in markets may be quashing appetite to complete transactions By Paul Bonanos, Director of Biopharma IntelligenceThe high volatility that has roiled biotech markets in early 2025 may be slowing blockbuster M&A activity to a crawl. It’s been three months since a biopharma company paid at least $1 billion to buy another, marking the longest such stretch since 2021.
By Paul Bonanos Verified| BioCentury Verified ARTICLE | FinancePlus: Caris, Raythera, Immunitybio among those raising cash By Paul Bonanos, Director of Biopharma IntelligenceImmunology start-up Merida emerged from stealth mode this week with $121 million in series A cash to develop therapies that target pathogenic autoantibodies and the B cells that produce them. The company originated as a project in the hands of Dario Gutierrez during a stint as an entrepreneur-in-residence at Third Rock Ventures.
By Paul Bonanos Verified| BioCentury Verified ARTICLE | DealsUncertainty in markets may be quashing appetite to complete transactions By Paul Bonanos, Director of Biopharma IntelligenceThe high volatility that has roiled biotech markets in early 2025 may be slowing blockbuster M&A activity to a crawl. It’s been three months since a biopharma company paid at least $1 billion to buy another, marking the longest such stretch since 2021.
Company Info
BioCentury
BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.
'+1 650-595-5333
Founded: 1992